Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.112EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.190EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.552EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
M.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.333EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.429EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.463EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
U.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.373EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.80EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.433EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.242EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.449EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.152EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.146EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
D.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.177.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.1.445EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
AY.21 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.619.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.12.1 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.260EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.456EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.16 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19429.5South Korea
BA.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.428EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.374EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.63 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.377EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used